IQVIA (IQV) Competitors $200.66 -4.36 (-2.13%) Closing price 10/7/2025 03:59 PM EasternExtended Trading$200.91 +0.25 (+0.13%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IQV vs. BRKR, ICLR, MEDP, TECH, A, CRL, DHR, MTD, TMO, and WATShould you be buying IQVIA stock or one of its competitors? The main competitors of IQVIA include Bruker (BRKR), Icon (ICLR), Medpace (MEDP), Bio-Techne (TECH), Agilent Technologies (A), Charles River Laboratories International (CRL), Danaher (DHR), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), and Waters (WAT). IQVIA vs. Its Competitors Bruker Icon Medpace Bio-Techne Agilent Technologies Charles River Laboratories International Danaher Mettler-Toledo International Thermo Fisher Scientific Waters Bruker (NASDAQ:BRKR) and IQVIA (NYSE:IQV) are related companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings. Is BRKR or IQV more profitable? IQVIA has a net margin of 7.88% compared to Bruker's net margin of 2.31%. IQVIA's return on equity of 30.05% beat Bruker's return on equity.Company Net Margins Return on Equity Return on Assets Bruker2.31% 17.89% 5.38% IQVIA 7.88%30.05%6.77% Which has preferable valuation and earnings, BRKR or IQV? IQVIA has higher revenue and earnings than Bruker. IQVIA is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBruker$3.37B1.56$113.10M$0.5266.46IQVIA$15.41B2.21$1.37B$6.9129.04 Which has more risk & volatility, BRKR or IQV? Bruker has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, IQVIA has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Do analysts prefer BRKR or IQV? Bruker presently has a consensus target price of $51.00, indicating a potential upside of 47.57%. IQVIA has a consensus target price of $230.32, indicating a potential upside of 14.78%. Given Bruker's higher possible upside, research analysts clearly believe Bruker is more favorable than IQVIA.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bruker 1 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.36IQVIA 0 Sell rating(s) 7 Hold rating(s) 18 Buy rating(s) 0 Strong Buy rating(s) 2.72 Does the media prefer BRKR or IQV? In the previous week, IQVIA had 8 more articles in the media than Bruker. MarketBeat recorded 19 mentions for IQVIA and 11 mentions for Bruker. IQVIA's average media sentiment score of 1.11 beat Bruker's score of 0.66 indicating that IQVIA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 3 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive IQVIA 14 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in BRKR or IQV? 79.5% of Bruker shares are held by institutional investors. Comparatively, 89.6% of IQVIA shares are held by institutional investors. 27.3% of Bruker shares are held by company insiders. Comparatively, 1.6% of IQVIA shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryIQVIA beats Bruker on 13 of the 16 factors compared between the two stocks. Get IQVIA News Delivered to You Automatically Sign up to receive the latest news and ratings for IQV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IQV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IQV vs. The Competition Export to ExcelMetricIQVIAMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$34.85B$7.07B$6.12B$22.14BDividend YieldN/A1.15%5.70%3.57%P/E Ratio29.0427.2985.6029.64Price / Sales2.21201.06612.8195.37Price / Cash12.3522.0037.7824.65Price / Book6.005.2713.254.61Net Income$1.37B$178.04M$3.30B$1.01B7 Day Performance-1.61%3.60%3.87%-0.14%1 Month Performance6.89%10.60%8.33%2.28%1 Year Performance-11.52%32.96%88.97%14.59% IQVIA Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IQVIQVIA4.8599 of 5 stars$200.66-2.1%$230.32+14.8%-11.0%$34.85B$15.41B29.0488,000Positive NewsBRKRBruker4.9484 of 5 stars$30.88-0.5%$51.30+66.1%-47.6%$4.69B$3.37B59.3911,396ICLRIcon4.0173 of 5 stars$163.44-0.2%$216.67+32.6%-35.7%$13.20B$8.28B16.8141,900MEDPMedpace4.2385 of 5 stars$500.76+0.8%$422.27-15.7%+59.9%$14.07B$2.11B37.235,900Positive NewsTECHBio-Techne4.8331 of 5 stars$52.23+0.7%$70.42+34.8%-19.5%$8.13B$1.22B113.553,100Analyst ForecastAAgilent Technologies3.9089 of 5 stars$123.70+0.3%$140.08+13.2%-3.7%$35.07B$6.51B29.0417,900Analyst ForecastCRLCharles River Laboratories International4.3916 of 5 stars$146.88-1.1%$177.07+20.6%-10.1%$7.23B$4.05B-110.4320,100Analyst UpgradeDHRDanaher4.98 of 5 stars$185.87+0.6%$245.91+32.3%-22.4%$133.09B$23.88B39.5563,000Positive NewsAnalyst ForecastMTDMettler-Toledo International3.9684 of 5 stars$1,191.70-1.1%$1,325.56+11.2%-10.9%$24.55B$3.87B30.1817,300Analyst ForecastTMOThermo Fisher Scientific4.889 of 5 stars$461.95-0.5%$588.35+27.4%-9.9%$174.44B$42.88B26.72125,000Positive NewsAnalyst ForecastWATWaters4.6384 of 5 stars$289.19-0.9%$378.73+31.0%-8.9%$17.21B$2.96B26.087,600Trending News Related Companies and Tools Related Companies Bruker Alternatives Icon Alternatives Medpace Alternatives Bio-Techne Alternatives Agilent Technologies Alternatives Charles River Laboratories International Alternatives Danaher Alternatives Mettler-Toledo International Alternatives Thermo Fisher Scientific Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IQV) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQVIA Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IQVIA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
